Dr. Cinar is formally trained as pharmacist and pharmacologist. He joined the National Institute on Alcohol Abuse and Alcoholism (NIAAA)/NIH in 2009 and completed his postdoctoral training in 2014 under the mentorship of Dr George Kunos. He is a staff scientist in the Laboratory of Physiologic Studies at the NIAAA. Dr. Cinar has expertise in the pharmacology of cannabinoid receptors and in the use of liquid chromatography/tandem mass spectrometry as a bioanalytical tool to explore the biology of lipid signaling systems such as endocannabinoids. His studies have focused on the role of the endocannabinoid system in metabolic regulation in complex disorders such as diabetes, obesity, fatty liver disease and fibrotic disorders. Dr. Cinar has also expertise in structure-based drug design and in analyzing the pharmacodynamics and pharmacokinetics of novel compounds. Dr. Cinar is interested in polypharmacology approach and functional selectivity for drug design strategy for developing more efficient and safer therapeutic modalities for complex chronic diseases.